Gulf Times - Biogen
First patient set to receive controversial Biogen Alzheimer's drug

First patient set to receive controversial Biogen Alzheimer's drug

A US hospital on Wednesday will give the first infusion of an expensive, controversial new Alzheimer's drug from Biogen Inc before Medicare had even said what it will pay for - and with some doctors upset by its approval last week.

Biogen, Eisai revive plans for Alzheimer's drug, surprising market

Biogen, Eisai revive plans for Alzheimer's drug, surprising market

Biogen Inc revived plans on Tuesday to seek US approval for Alzheimer's treatment aducanumab